Cell-based screening methods
AssigneeMerrimack Pharmaceuticals, Inc.
InventorsMichael H. Cardone, Michael Yaffe
Life of this patent
Estimating the term…
Abstract
Cell-based screening methods for determining kinase activity are provided. The methods utilize existing cellular pathways that are regulated by kinases. In one embodiment, various components of a ubiquitin-mediated degradation pathway are modified to create an assay that can be used to screen for a molecule that modulates the activity of a kinase of interest that otherwise does not regulate the degradation pathway. In another embodiment, various components of a protein translocation pathway are modified to screen for a molecule that modulates the activity of a kinase of interest that otherwise does not regulate the translocation pathway.
Claims4
A fusion protein comprising a genetically altered signaling enzyme and a label, said signaling enzyme comprising, in its unaltered state, an E3 ubiquitin ligase (E3 ligase), said alteration producing an adapter module in said signaling enzyme capable of binding to a phosphorylation substrate that said enzyme does not bind in its unaltered state, said binding being regulated by a kinase.
Dependencies are inferred from the claim text.